ISPOR - PCN97 A COST-UTILITY ANALYSIS ON THE USE OF TRASTUZUMAB ) METASTATIC BREAST CANCER (MBC) FROM THE PERSPECTIVE OF THE UK NATIONAL HEALTH SERVICE (NHS)

Full Text

PCN97 A COST-UTILITY ANALYSIS ON THE USE OF TRASTUZUMAB ) METASTATIC BREAST CANCER (MBC) FROM THE PERSPECTIVE OF THE UK NATIONAL HEALTH SERVICE (NHS)

Abstract

Authors

S McNamara L Moore J Ray

Back to Volume 13, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now